FibRx Derm, Inc. — Form D/A
FibRx Derm, Inc. of BERKELEY, CA, a company, filed a Form D amendment with the SEC on 2020-05-14. The offering totals $6.8M, of which $4.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-14
- Form: D/A
- Accession: 0001764872-20-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.8M
- Amount sold: $4.2M
- Remaining: $2.5M
- Investors: 5
- Date of first sale: 2019-01-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-330595
Issuer
- Name: FibRx Derm, Inc.
- CIK: 0001764872
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 904 ALVARADO ROAD, BERKELEY, CA, 94705
- Phone: 617-520-6662
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Mark de Souza | Director | Hingham, MA |
| James W Fordyce | Director | Berkeley, CA |
| Mark de Souza | Executive Officer | Hingham, MA |
| James W Fordyce | Executive Officer | Berkeley, CA |
Other filings by this issuer (1)
More